Headline News about Crispr Therapeutics Ag![]() ![]() ![]() ![]() ![]()
Analyst Initiates Coverage On This Peer Lagging Gene-Editing Stock
February 01, 2023
Via Benzinga
![]() ![]() ![]()
Expert Ratings for CRISPR Therapeutics
January 05, 2023
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|